CVS Health Corporation is set to report its latest quarterly earnings on Tuesday, May 5th, with a consensus estimate EPS of $2.21.
CVS stock is currently priced at $81.23, up by $2.87 (3.66%) from the previous close of $78.36. The trading volume is at $3.16 million, representing a 39.31% increase relative to the average.
In the most recent quarterly earnings report on Monday, February 9th, CVS surpassed expectations with an EPS of $2.32, reflecting a positive trend compared to the consensus estimate of $0.99.
CVS offers a forward dividend yield of 3.3% and a dividend per share of 66.5 cents. The year-over-year dividend per share has increased by 33.3333 cents to $3.33 on a trailing twelve-month basis.
The company maintains a healthy cash flow position with free cash flow amounting to $2.61 billion and operating cash flow at $3.39 billion. Notably, debt repayment stands at $1.27 billion.
With a net income of $2.94 billion, CVS demonstrates solid profitability. The company generated $105.69 billion in revenue, resulting in a gross profit of $13.57 billion.
Key ratios show positive performance metrics for CVS, including a net profit margin of 2.78%, return on equity of 3.91%, and a price-to-earnings ratio of 8.56.
The balance sheet reveals a strong financial position for CVS, with total assets amounting to $261 billion and total liabilities at $185.68 billion.
This comprehensive analysis indicates CVS's robust performance and financial stability ahead of its upcoming earnings release.
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.